GREB1 and other genes have been proposed as putative salivary biomarkers for the non-invasive detection of lung cancer [41,42] as well as a target molecule of the Wnt/β-catenin pathway required for hepatoblastoma progression [43]. This evidence concerns the gene GREB1 and hepatoblastoma.